“…Also, many possible prognostic factors have been identified in advanced pancreatic cancer (Table 1), most derived from retrospective studies based on small numbers of patients resulting in analyses that may be underpowered. A total of 34 possible factors were identified from 36 studies (4 randomised controlled trials; Johnson et al, 2001;Berlin et al, 2002;Ducreux et al, 2002;Maisey et al, 2002) and 32 consecutive series (Friedman and van den Eeden, 1993;Yasue et al, 1994;Falconer et al, 1995;Lundin et al, 1995;Ishii et al, 1996;Rothenberg et al, 1996;Shibamoto et al, 1996;Cubiella et al, 1999;Storniolo et al, 1999;Halm et al, 2000;Terwee et al, 2000;Trigui et al, 2000;Ueno et al, 2000;Ikeda et al, 2001;Ridwelski et al, 2001;Tas et al, 2001;Tsuruta et al, 2001;Saad et al, 2002;Bachmann et al, 2003;Engelken et al, 2003;Fujino et al, 2003;Karayiannakis et al, 2003;Micke et al, 2003;Ohigashi et al, 2003;Paillaud et al, 2003;Stemmler et al, 2003;Talar-Wojnarowska et al, 2003;Ziske et al, 2003;Gupta et al, 2004;Kuhlmann et al, 2004;Watanabe et al, 2004;Ni et al, 2005) of which 15 had o100 patients (Yasu...…”